- Home
- ZJYL vs LXEO Comparison
ZJYL vs LXEO Comparison
Compare ZJYL & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZJYL
- LXEO
- Stock Information
- Founded
- ZJYL 2006
- LXEO 2017
- Country
- ZJYL China
- LXEO United States
- Employees
- ZJYL N/A
- LXEO N/A
- Industry
- ZJYL Industrial Specialties
- LXEO
- Sector
- ZJYL Consumer Discretionary
- LXEO
- Exchange
- ZJYL Nasdaq
- LXEO Nasdaq
- Market Cap
- ZJYL 320.9M
- LXEO 314.1M
- IPO Year
- ZJYL 2023
- LXEO 2023
- Fundamental
- Price
- ZJYL $1.06
- LXEO $6.47
- Analyst Decision
- ZJYL
- LXEO Strong Buy
- Analyst Count
- ZJYL 0
- LXEO 7
- Target Price
- ZJYL N/A
- LXEO $22.71
- AVG Volume (30 Days)
- ZJYL 323.8K
- LXEO 621.5K
- Earning Date
- ZJYL 07-26-2024
- LXEO 11-13-2024
- Dividend Yield
- ZJYL N/A
- LXEO N/A
- EPS Growth
- ZJYL N/A
- LXEO N/A
- EPS
- ZJYL 0.02
- LXEO N/A
- Revenue
- ZJYL $20,125,185.00
- LXEO N/A
- Revenue This Year
- ZJYL N/A
- LXEO N/A
- Revenue Next Year
- ZJYL N/A
- LXEO N/A
- P/E Ratio
- ZJYL $56.81
- LXEO N/A
- Revenue Growth
- ZJYL 0.75
- LXEO N/A
- 52 Week Low
- ZJYL $0.56
- LXEO $5.77
- 52 Week High
- ZJYL $25.49
- LXEO $22.33
- Technical
- Relative Strength Index (RSI)
- ZJYL 24.53
- LXEO 34.49
- Support Level
- ZJYL $0.96
- LXEO $5.77
- Resistance Level
- ZJYL $2.20
- LXEO $11.72
- Average True Range (ATR)
- ZJYL 0.21
- LXEO 0.86
- MACD
- ZJYL -0.05
- LXEO -0.13
- Stochastic Oscillator
- ZJYL 8.06
- LXEO 11.76
About ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is primarily engaged in the design, development, manufacturing, and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's products are sold to distributors in both China and in overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, nursing products, and conlo products.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.